S-ALPSerum Activity of Alkaline Phosphatase
References in periodicals archive ?
These results showed that there was better S-ALP control with Firmagon than leuprolide, which is an important finding for physicians treating patients with prostate cancer because of S-ALP's association with skeletal metastases," commented Professor Fritz SchrE[micro]der, Professor of Urology, Erasmus Medical Center, Rotterdam, the Netherlands.
Effects of treatment on S-ALP levels were analyzed by baseline prostate cancer disease stage (localized, locally advanced or metastatic).
S-ALP levels were also suppressed during leuprolide treatment but dropping below baseline levels by day 84.